Estimation of blood lead levels in the French population using two complementary approaches: Esteban (2014–2016) as part of the human biomonitoring program and the national surveillance system for childhood lead poisoning (2015–2018).

Surveillance de l’exposition au plomb de la population française par deux approches complémentaires : l’étude Esteban (2014-2016), dans le cadre du programme national de biosurveillance et le système national de surveillance du saturnisme de l’enfant (2015-2018).

Publié le 29 août 2022

Widely used for centuries, lead is a toxic pollutant that remains present in the environment to the detriment of the overall population. Despite an overall decrease in general population exposure to lead, the Institute for Health Metrics and Evaluation (IHME) estimated in 2019 that lead exposure still accounted for 62.5% of the global burden of idiopathic developmental disability, 8.2% of hypertensive heart disease, 4.7% of strokes, 4.6% of ischemic heart disease, and 3% of chronic kidney disease.

In France, the Grenelle Environnement law (n◦2009-967, adopted on 3 August 2009) led to the implementation of a national biomonitoring programme designed to estimate the exposure of the general population to various environmental substances. Within this programme, the Esteban study was set up to describe and monitor levels of impregnation in the general population for about 100 substances, including lead.

In addition, the non-threshold and sometimes irreversible toxic effects of lead (nephrotoxicity, neurotoxicity, reprotoxicity, fetotoxicity, etc.) justify ensuring that low levels of exposure are maintained and that blood lead levels are monitored. Childhood lead poisoning (in the population under the age of 18) can have serious irreversible consequences, particularly on cognitive and psychomotor development, and can be harmful even at low concentrations. For this reason, a mandatory reporting system for cases of childhood lead poisoning was set up as one of several methods of surveillance.

Despite the European directives that regulate the use of lead, close monitoring remains necessary because of its persistence in the environment and its non-threshold toxicity. So, given this context, what do we know about the current situation concerning lead exposure in the French population? The article recently published in the review Environmental Research addresses this question, specifically concentrating on exposure conditions, some of which remain under-documented, and the complementary approaches used by Santé publique France. 

3 questions for: Amivi Oleko  and Marie Pecheux, Santé publique France

Amivi OLEKO - Santé publique France
Marie Pecheux, Santé publique France

Your article draws on two approaches to lead exposure monitoring in the French population. What are these approaches and which populations are concerned ?

The work carried out by Santé publique France to monitor lead exposure in the French population involves two approaches: biomonitoring studies such as Esteban (health study on environment, biosurveillance, physical activity and nutrition) and the national surveillance system of blood lead levels (SNSPE).  

The Esteban epidemiological study was carried out between 2014 and 2016. It determined lead impregnation levels in the general French population aged 6 to 74 years, analysed determinants related to population exposure to lead, and tracked temporal trends. The previous study to measure blood lead levels in the French population was the National Nutrition and Health Survey (ENNS), which was conducted on adults between 2006 and 2007. In the period between the ENNS and Esteban, the average blood lead level of adults (18-74 years) decreased from 27.5 µg/L to 18.5 µg/L.

The SNSPE, on the other hand, targets children from 0 to 17 years of age at risk of overexposure to lead. These situations of exposure may result from their habitat or living environment (e.g., lead paint), leisure activities (e.g., shooting sports (1)), or lifestyle and cultural practices (e.g., use of traditional remedies containing lead), but also from professional training activities (e.g., apprenticeship in stained glass manufacturing or renovation). This surveillance system includes the mandatory reports of lead poisoning cases and concerns children who have had at least one blood lead test. 

The SNSPE therefore measures the incidence of lead poisoning in children considered at risk of overexposure, which is difficult to capture in biomonitoring studies such as the Esteban study. 

The average blood lead level of children included in the SNSPE between 2015 and 2018 was 18.6 µg/L. This level was 9.9 µg/L for children aged 6 to 17 years, according to the Esteban study. As a point of reference, in its report of 23 May 2014, the High Council for Public Health (HCSP) (2) advocates a policy of reducing exposures to the lowest possible level in view of the non-threshold effects of lead. Its recommendations include a rapid intervention protocol for a blood lead level of 50 μg/L and a vigilance threshold at 25µg/L. However, these levels do not correspond to a lead safety threshold, as this metal is a toxicant considered to have no threshold. Effects on the cognitive abilities of young children have been observed with blood lead levels below the vigilance threshold. It should be noted that these thresholds also concern pregnant women.

Documenting exposure conditions and screening for childhood lead poisoning provide key support for public decisions. What are the identified risk factors ?

The Esteban study showed that, despite a decrease in blood lead levels, the exposition of the population was generalized. Lead was quantified in all analysed blood samples. The search for the determinants of exposure revealed known exposure factors (diet, tap water and alcohol consumption, tobacco consumption (cigarettes), age, sex, housing construction date, parents' professional activity (risk factor for children), etc.). Esteban, for example, showed that children aged 6-10 years were more impregnated than older children (11-17 years), and that girls were less impregnated than boys. The study also showed the persistence of those lead exposure factors already known and described in the scientific literature, and has made it possible to define Reference Exposure Values (REV) (3) for lead. These values serve as a reference for comparing blood lead levels measured in an individual or a subgroup of the French population. It is thus possible to identify individuals who are overexposed compared to the reference population. As an example, in 2019, post-fire monitoring of the Notre-Dame Cathedral in Paris was set up, and the blood lead levels of children screened around Notre-Dame were compared to those of children in the Esteban study (4).

Of the 2,511 incident cases of lead poisoning reported in the SNSPE between 2015 and 2018, one-third resided in French Guiana and nearly one-third resided in Île-de-France. The Provence-Alpes-Côte d'Azur region accounted for nearly 16% of cases. The majority of cases were boys (52% of incident cases) with an average sex ratio (M/F) of 1.11. Children under 3 years of age accounted for 40% of lead poisoning cases, of which 45% were under 1 year of age. 

The main environmental risk factors identified by physicians at the time of prescription were related to old and/or dilapidated housing, the presence of other poisoned children in their environment, and pica behaviour. 

The presence of symptoms was infrequent among incident cases (8%), and mainly consisted of behavioural disorders such as irritability or agitation, sometimes associated with learning difficulties; digestive disorders such as abdominal pain and constipation; neurological signs (headaches, cerebellar ataxia, mental retardation) and autism-spectrum disorders. As clinical signs are not very present and not very specific for lead poisoning, these results show the importance of identifying poisoned children through the search for environmental risk factors.

What are the prospects for the national biomonitoring program concerning lead exposure? What preventive actions and which populations should be prioritized in light of the current knowledge in order to reduce exposure?

Lead exposure remains a public health problem in France. Continuing to raise awareness among health professionals about the sources of lead exposure allows better identification of children at risk. The results of Esteban and the SNSPE confirm the need to continue monitoring lead exposure and to continue documenting the associated risk factors. They show that efforts related to public policies (replacement of lead pipes, lead diagnosis in housing, lead-free gasoline, renovation of old housing, etc.) must be continued. Recently, cases of lead poisoning related to metal recovery activities have been identified, requiring the implementation of specific prevention actions (5). 

Given the toxicity of lead and its harmful effects on health, maintaining the lowest possible blood lead levels is a public health issue. The results of the national biomonitoring program are now used to support public decisions to continue efforts to reduce lead exposure (e.g., regulations regarding the presence of lead in housing and drinking water pipes).

The Esteban study showed a generalized exposure to chemical substances in the French population via a substance-by-substance approach, allowing the identification of the determinants of exposure to a chemical product. In the future, it will be important to look at multiple exposures to substances, which will make it possible to assess the reality of exposure to a cocktail of chemicals. In order to verify the continued decline in levels in the general population and evaluate the persistence of risk factors, the next biomonitoring study should include the measurement of blood lead, particularly in young children. It would also be appropriate to obtain, through collaboration with other health agencies, environmental data to couple with biomonitoring data in order to identify emerging sources of exposure.

The most vulnerable populations remain pregnant women and children, including young people in vocational training.

HBM4EU: A European initiative for the harmonization of biomonitoring studies

The HBM4EU research program (2017-2022), initiated by the European Commission, aims to develop biomonitoring in Europe and to harmonize practices. Santé publique France is involved as the pilot of the national biomonitoring program. One of the objectives of this program is to collect human biomonitoring data from citizens across Europe and, through the measurement of biomarkers, describe their level of impregnation by environmental chemical substances in order to contribute to the improvement of related public policies.

The article "Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants" recently published in the International Journal of Environmental Research and Public Health* presents the approach taken by HBM4EU to carry out a large-scale European biomonitoring study.  The HBM4EU biomonitoring study involves more than 3,000 participants in each of three age categories across the European Union: children aged 6-12 years, adolescents aged 12-18 years and adults aged 20-39 years. Such a large sample size provides an accurate picture of the exposure levels of the European population and significantly increases the power of the analyses performed. Socio-demographic information (lifestyle, health status, environment and diet) is collected for each participant. Data will be published for several biomarkers (blood and/or urine) such as bisphenols, phthalates, pyrethroids, flame retardants, per- and polyfluoroalkyl substances (PFAS), or arsenic, providing a baseline for the European strategy and recommendations to improve the sampling frame of future national biomonitoring surveys.

*Gilles L, Govarts E, Rodriguez Martin L, Andersson AM, Appenzeller BMR, Barbone F, Castaño A, Coertjens D, Den Hond E, Dzhedzheia V, Eržen I, López ME, Fábelová L, Fillol C, Rambaud L, et al. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants. Int J Environ Res Public Health. 2022 Jun 1;19(11):6787. doi: 10.3390/ijerph19116787. PMID: 35682369; PMCID: PMC9180444.

For more information: 

  • Santé et environnement : données de biosurveillance et études d'imprégnation. Bull Epidemiol Hebd. 2020-07-07;(18-19):351-400
  • Angerer J, Ewers U, Wilhelm M. Human biomonitoring : State of the art. Int. J. Hyg. Environ.-Health 210 (2007) 201–228.
  • Rambaud L, Fréry N, Tagne-Fotso R, El Yamani M. Implication de Santé publique France au sein du projet HBM4EU pour développer une biosurveillance environnementale et professionnelle européenne. Bull Epidémiol Hebd. 2020;(18-19):390-4. 
  • Fillol C, Oleko A, Saoudi A, Zeghnoun A, Balicco A, Gane J, Rambaud L, Leblanc A, Gaudreau É, Marchand P, Le Bizec B, Bouchart V, Le Gléau F, Durand G, Denys S. Exposure of the French population to bisphenols, phthalates, parabens, glycol ethers, brominated flame retardants, and perfluorinated compounds in 2014-2016: Results from the Esteban study. Environ Int. 2021 Feb;147:106340. doi: 10.1016/j.envint.2020.106340. Epub 2021 Jan 12. PMID: 33422968.

(1) Review of screening for lead poisoning in children (0-17 ans) in relation to shooting range attendance.

2) HCSP report of 23 May 2014 : HCSP report 23 May 2014: Update of the practical guide to screening and management of lead exposure in children and pregnant women).

(3)  REV: corresponding to the 95th percentile of the distribution.

(4) Etchevers A. Surveillance des plombémies infantiles réalisées à la suite de l’incendie de la cathédrale Notre-Dame de Paris en 2019. Saint-Maurice : Santé publique France, 2021. 29 p. 

(5) Brabant G, Etchevers A, Spanjers L, Coudret S, Comba M, Clarysse É, et al. Activités à risque d’exposition au plomb et saturnisme chez les enfants de familles de gens du voyage en Charente, 2017-2019. 

For more information